6 of these genes (TP53, KRAS, BRAF, VHL, PIK3CA, AKT1) were significantly enriched in both primary and metastatic cancers, and only TP53 and KRAS in more than one cancer type, 8 and 2, respectively (Figure S4). This evidence concerns the gene KRAS and cancer.